Mizoribine is an immunosuppressive medication that inhibits purine synthesis, reducing lymphocyte proliferation. It is mainly used to prevent organ transplant rejection and to treat autoimmune diseases including nephrotic syndrome and lupus. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Mizoribina and Mizoribinum. Its PubChem CID is 104762.
Mizoribine
| CAS No | 50924-49-7 |
|---|---|
| Molecular Formula | C9H13N3O6 |
| Molecular Weight | 259.22 g/mol |
| Synonyms | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mizoribine is an immunosuppressive medication that inhibits purine synthesis, reducing lymphocyte proliferation. It is mainly used to prevent organ transplant rejection and to treat autoimmune diseases including nephrotic syndrome and lupus.
The listed CAS number is 50924-49-7.
The listed molecular formula is C9H13N3O6.
The listed molecular weight is 259.22 g/mol.
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide.
The source lists Mizoribina and Mizoribinum.